Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Chacruna Institute Releases its Guide to RFRA and Best Practices for Psychedelic Plant Medicine Churches

The Chacruna Institute for Psychedelic Plant Medicines has released its comprehensive Guide to RFRA and Best Practices for Psychedelic Plant Medicine Churches. This free publication aims to inform churches using psychedelic plant medicine as a sacrament on how to better establish their operation and rights under the Religious Freedom Restoration Act (RFRA).


News provided by

Chacruna Institute for Psychedelic Plant Medicines

Nov 27, 2021, 17:40 ET

Share this article

Share toX

Share this article

Share toX


SAN FRANCISCO, Nov. 27, 2021 /PRNewswire-PRWeb/ -- On November 25th, 2021, the Chacruna Institute for Psychedelic Plant Medicines released its Guide to RFRA and Best Practices for Psychedelic Plant Medicine Churches. This Guide is a comprehensive resource on the Religious Freedom Restoration Act (RFRA) and how a church using psychedelic plant medicine as sacrament can be informed by the law in terms of its operation and establishing its rights under RFRA. Chacruna is releasing this Guide for free to the public, recognizing the need of psychedelic plant medicine church communities in the United States for organized and clear information.

"There are hundreds of sincere and legitimate plant medicine communities operating in the United States living under uncertain conditions," said Bia Labate, Ph.D., Chacruna's Executive Director. "This Guide teaches communities to learn about their rights, and how to better protect themselves. When we talk about religious liberty, we are also talking about responsibilities. If we have rights, we also have obligations! This Guide provides instructions on how to better follow legal requirements and protocols, including everything from the big picture to small details. It is a must-read for every single sincere practitioner in this country."
By reading the Guide's explanation of the RFRA test, applicable laws, government criteria, and the history of previous court and government agency decisions and analysis, a psychedelic plant medicine church can make informed decisions in how it articulates its sincere religious beliefs and operates.

u201cThis Guide is written to simply explain the laws and basic information needed by a psychedelic plant medicine church to make informed decisions and understand its rights and risks by operating in the United Statesu201d -Allison Hoots, member of Chacrunau2019s Council for the Protection of Sacred Plants

Post this

"This Guide is written to simply explain the laws and basic information needed by a psychedelic plant medicine church to make informed decisions and understand its rights and risks by operating in the United States," said Allison Hoots, Esq., member of Chacruna's Council for the Protection of Sacred Plants. "We believe that information is power, and it is this Guide's intent to empower psychedelic plant medicine churches with sincerely held religious beliefs. An understanding of the law and legal decisions relating to RFRA gives crucial context to navigating the right to religious exercise."

While RFRA provides mechanisms to protect sincere religious exercise, churches using psychedelic plant medicines are not exempt from criminal prosecution simply because they claim religious use. "The psychedelic renaissance is expanding rapidly, but the law moves slowly. In the time it will take to fully decriminalize and ultimately legalize plant medicine, practitioners are at risk due to outdated, limited, and ignorant laws that criminalize natural medicines or sacraments," said Sean McAllister, Esq., member of Chacruna's Board of Directors. "In my law practice, I see many people operating under urban myths around plant sacrament legality. This Guide provides a clear presentation of the actual legal issues around plant sacrament use."

The Guide contains basic but essential information, such as how RFRA case law frames decisions relating to incorporation, tax-exempt status, pre-screening procedures, limiting liability, emergency procedures, selection of a name, advertising, sacrament issues, and other aspects of operation. While every psychedelic plant medicine church should make legal choices and establish procedures based on their own religious beliefs and with legal counsel, this Guide brings into focus where such decisions may be scrutinized when asserting the right to religious exercise under RFRA.

"It is essential for the safe and free religious practice of psychedelic plant medicine churches that they have access to reliable information on best practices for operating their communities as legal organizations in the United States. The Guide is an educational deep-dive into the legal case law that can show churches what they already are doing well, and what blind spots they may have about their organizational structure and operations," said Brian Anderson, M.D., member of Chacruna's Board of Directors.
The Guide's overview of RFRA cases and operational concerns is accessible to practitioners and attorneys alike, explaining the uncertain landscape of protection of religious exercise with psychedelic plant medicines.

Chacruna is proud to present the Guide so that psychedelic plant medicine churches can use this crucial information at a time when such religious use is both burdened by government laws and actions and being recognized more widely and publicly as a practice with integrity. "This immense effort of the Guide underscores Chacruna's commitment to empowering the wellbeing of the psychedelic plant medicine church community," said Robert Heffernan, Program Director of Chacruna's Council for the Protection of Sacred Plants.

On December 15, 2021, at 12pm PT/3pm ET, Chacruna is hosting "Protecting Sincere Psychedelic Churches: Chacruna's Guide to the Law and Best Practices," an online launch event for the Guide with a panel of representatives with experience with these specific issues, including Bia Labate, Allison Hoots, Jack Silver, Mason Marks, and Vicki Kraft. Mark your calendar and join Chacruna and this fantastic panel to launch the Guide to RFRA and Best Practices for Psychedelic Plant Medicine Churches.
You can sign up for the event here and download the guide here.

About Chacruna Institute
The Chacruna Institute for Psychedelic Plant Medicines, an organization co-founded by Brazilian anthropologist Dr. Bia Labate and American psychologist Dr. Clancy Cavnar, produces high-quality research on plant medicines and psychedelics and helps propagate academic knowledge in more accessible formats. We educate the public and create cultural understanding and legitimacy regarding these substances so that they may cease to be stigmatized and outlawed. Chacruna also promotes a bridge between the world of plant medicines and the emergent field of psychedelic science, between "traditional ceremonial use" and clinical and therapeutic settings, bringing the knowledge and perspectives of the social sciences to health care professionals and practitioners of psychedelic-assisted therapy. Finally, we foster cultural and political reflections on the field of psychedelic science and facilitate conversations about controversial topics that have been simmering on the sidelines as psychedelics go mainstream.

About the Guide
This Guide gives psychedelic plant medicines churches using sacrament in religious exercise in the United States the knowledge to understand the mechanisms through which protection is offered under the Religious Freedom Restoration Act (RFRA). While RFRA automatically provides protection for sincere religious exercise, not every church using psychedelic plant medicines will be exempt from criminal prosecution simply because they claim religious use. The Guide explains the balancing test under RFRA, which applies scrutiny to the whole of a church's religious beliefs, spiritual practices, and sincerity—but where the government's interests in prohibiting this use will be scrutinized, as well. The Guide uses its overview of the law and RFRA test to frame how psychedelic plant medicine churches can make informed decisions about incorporation, tax-exempt status, pre-screening procedures, limiting liability, and other aspects of operation. While every psychedelic plant medicine church should make legal choices and establish procedures based on their own religious beliefs and with legal counsel, this Guide brings into focus where such decisions may be scrutinized when asserting the right to religious exercise under RFRA.

Download the guide here

Media Contact

Francisco Rivarola, Chacruna Institute for Psychedelic Plant Medicines, 1 415-390-6157, [email protected]

SOURCE Chacruna Institute for Psychedelic Plant Medicines

Modal title

Blurb 1
Blurb 1
Blurb 2
Blurb 2
Mushrooms illustration
Mushrooms illustration
Ayahuasca illustration
Ayahuasca illustration
Rectangular image of publication Cover photo for publication in square format
Rectangular image of publication Cover photo for publication in square format
Blurb 1 Blurb 2 Mushrooms illustration Ayahuasca illustration Rectangular image of publication Cover photo for publication in square format

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.